This site is intended for healthcare professionals only
LoginRegister
Biocon Secures Rs 4,150 Cr Through QIP to Buy Out Viatris Stake in Biologics ArmBiocon Biologics, Amgen strike settlement, clear path for Bosaya, Aukelso in US
USFDA Approves Bionpharmas Generic HIV Drug EtravirineLupin bags USFDA approval for Rivaroxaban for Oral Suspension for thromboprophylaxis in pediatric...
Pharma Firm Slapped Rs 15 Lakh for Infringing IPCAs ZERODOL TrademarkBombay HC Quashes Maharashtra FDA, CDSCO Stop-Production Orders Against 2 Pharma Firms
Alert does not reflect current situation: Indian Immunologicals on fake Abhayrab claimsIndian Immunologicals Launches Raksha-IBR, India's First DIVA Vaccine Against IBR
Antibiotics May Soon Carry Blue Strip as Health Ministry Moves to Fight AMRRajasthan Drug Official Under Probe for Misreporting Spurious Medicines
Intas Pharma Told to Narrow Margins, Extend Duration in Pembrolizumab Trial ProtocolIntas Pharma Told to Narrow Margins, Extend Duration in Pembrolizumab Trial Protocol
AbbVie Loses India Patent Bid for Cancer Drug Venetoclax, Generics Set to Enter MarketAbbVie to Launch Ovarian Cancer Drug ELAHERE in UK at US Price Levels
Kala Bio Halts Eye Drug Development After Phase 2b Trial FailureKala Bio Halts Eye Drug Development After Phase 2b Trial Failure
Novartis concludes acquisition of Tourmaline BioNovartis commences tender offer to buy Tourmaline Bio
AstraZeneca Gets SEC Nod to Update Lokelma Prescribing Information for Hyperkalemia TreatmentAstraZeneca to harmonise its listing structure across LSE, STO and NYSE
Johnson and Johnson Gets CDSCO Panel Nod for Talqetamab in Relapsed Multiple Myeloma, Phase IV Trial MandatedJnJ Tremfya gets USFDA nod for pediatric plaque psoriasis, active psoriatic arthritis
Amgen announces USD 650 million expansion of US manufacturingAmgen announces USD 650 million expansion of US manufacturing network
X